Clin2
NCT06613841Possibly a fitRecruiting

Brain tumor imaging study for glioblastoma patients

GlioblastomaRecurrent GlioblastomaGlioblastoma Multiforme of Brain

Part of Cancer clinical trials.

This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a new brain mass that looks like glioblastoma (GBM) or a growing lesion after prior glioblastoma treatment
  • Your doctor recommends surgery to remove the tumor
  • You are expected to live at least 3 more months
  • You are able to tolerate MRI and PET scans
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07628257Not yet recruiting
Brain Imaging and Thinking Patterns in Glioblastoma

This study uses advanced brain scans (PET and MRI) before surgery to understand how glioblastoma (an aggressive brain tumor) affects your brain's connections and thinking abilities. The goal is to help doctors better predict treatment outcomes and plan surgery more precisely.

Strasbourg
NCT05541042Not yet recruiting
MRI and PET scan results matched to tumor gene markers

This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.

Zhengzhou, Henan
NCT07461948Recruiting· Phase 3
Advanced imaging study for glioblastoma patients

This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.

Los Angeles, California
NCT06113705Recruiting
Better MRI and blood tests for glioblastoma treatment response

This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.

Rozzano
NCT07735819Not yet recruiting· Phase 2
PET/CT scan for people with glioma

This study uses a special PET/CT scan to take detailed pictures of gliomas (a type of brain tumor). It may help doctors understand your tumor better and plan your treatment.

Detroit, Michigan
NCT05555550Recruiting· Early Phase 1
PET-MRI scan to study low-grade brain tumors in children

This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.

Philadelphia, Pennsylvania

Hear when a new Glioblastoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.